Enfusion, Inc. (NYSE:ENFN) Might Not Be As Mispriced As It Looks
Enfusion Announces Date of Second Quarter 2024 Results
Insider Sale: Chief People Officer Bronwen Bastone Sells Shares of Enfusion Inc (ENFN)
Form 144 | Enfusion(ENFN.US) Officer Proposes to Sell 147.9K in Common Stocks
SEC FILLINGS DISCLOSED/ Jun 20, $Enfusion(ENFN.US)$ Officer Bastone Bronwen intends to sell 18,241 shares of its common stock on Jun 20, with a total market value of approximately $147.9K. Bastone B
FTV Capital Expands Internationally With Opening of London Office
Morgan Stanley Maintains Enfusion(ENFN.US) With Buy Rating, Maintains Target Price $11
KKR to Acquire Majority Ownership in Agiloft
Enfusion To Present at Upcoming Investor Events
William Blair Maintains Enfusion(ENFN.US) With Buy Rating
Buy Rating Affirmed for Enfusion on Strong Growth and Market Positioning Prospects
Insider Sale: Chief People Officer Bronwen Bastone Sells 34,059 Shares of Enfusion Inc (ENFN)
Enfusion(ENFN.US) Officer Sells US$325.26K in Common Stock
Enfusion Insider Sold Shares Worth $325,263, According to a Recent SEC Filing
Form 144 | Enfusion(ENFN.US) Officer Proposes to Sell 325.4K in Common Stocks
SEC FILLINGS DISCLOSED/ May 20, $Enfusion(ENFN.US)$ Officer Bastone Bronwen intends to sell 34,059 shares of its common stock on May 20, with a total market value of approximately $325.4K. Source:
Enfusion Insiders Sell US$24m Of Stock, Possibly Signalling Caution
Enfusion First Quarter 2024 Earnings: EPS Misses Expectations
Analysts Offer Insights on Technology Companies: Enfusion (ENFN), Vertex (VERX) and Shift4 Payments (FOUR)
Enfusion | 10-Q: Quarterly report
Enfusion Shares Fall Despite Higher Q1 Results
Express News | Enfusion Inc Q1 Shr View $0.04 -- Lseg Ibes Data